While experimental evidence suggests potential carcinogenic effects of increased iron load, there is a lack of data on iron status and cancer risk from epidemiological studies. Here, we evaluated prediagnostic serum concentrations of ferritin, iron and transferrin as well as transferrin saturation (TSAT) in relation to cancer risk and mortality in a prospective study by multivariable Cox regression analyses. A case-cohort sample of the population-based EPIC-Heidelberg Study including a random subcohort (n 5 2738) and incident cases of breast cancer (n 5 627), prostate cancer (n 5 554), lung cancer (n 5 195), colorectal cancer (n 5 256) and cancer death (n 5 759) was used. Ferritin levels were inversely associated with breast cancer risk in the multivariable Cox regression model, with a hazard ratio (HR) of 0.67 [95% confidence interval: 0.49, 0.92] for women in the highest quartile compared to those in the lowest quartile. Neither ferritin nor the other markers of iron status were significantly associated with colorectal, prostate or lung cancer risk. An inverse association was observed between ferritin and total cancer mortality (HR: 0.70 [0.53, 0.92]). There were no significant overall associations between serum iron, transferrin or TSAT and cancer mortality. The present findings do not support the notion of increased iron load constituting a cancer risk factor in the general population. By contrast, our analyses revealed inverse associations between ferritin levels and breast cancer risk as well as cancer mortality.
Introduction
High iron load has been linked to increased cancer risk in various preclinical studies. 1 The most prominent postulated underlying mechanism is iron-induced formation of hydroxyl radicals leading to oxidative tissue damage and subsequent carcinogenesis. 1 Another proposed mechanism is the suppression of CD 4 lymphocyte activity by excess iron, leading to an increased growth of neoplastic cells. 2 In addition, iron has been shown to enhance tumor growth via regulatory effects on hypoxiainducible factor-a (HIFa) protein and WNT signaling. 2, 3 Observations of such "ferrotoxic" effects of iron from basic science are paralleled by findings from observational studies among patients who suffer from hereditary hemochromatosis due to a genetic mutation in the hemochromatosis (HFE) gene. These patients show an augmented accumulation of iron in the liver and other tissues, and are thus at greater risk of developing hepatocellular carcinoma, 4 and possibly also gastric, colon and breast cancer. 5, 6 A further line of evidence on potential carcinogenic effects of high iron status comes from a randomized clinical trial (RCT) indicating reduced risk of visceral malignancies and mortality among male patients with peripheral artery disease, who underwent phlebotomy, with substantial decreases in serum ferritin, the routine marker for excess iron. 7 In contrast to the evidence summarized above, findings from population-based epidemiological studies on iron status and cancer risk have been contradictory. While heme iron intake was shown to be positively associated with risk of colorectal cancer in two meta-analyses, 8, 9 ferritin was inversely associated with colorectal cancer risk in three prospective studies. 10 Further prospective studies in which transferrin saturation (TSAT) and serum iron were used as markers of iron status have shown mixed results; some pointed to increased risks of overall cancer, 11, 12 and particularly breast cancer. 11, 13, 14 at higher serum iron and TSAT, whereas others did not reveal significant associations.
potential confounders such as C-reactive protein (CRP) were not taken into account, which is crucial given that iron biomarkers are affected by inflammation. 16, 17 Overall, there is a lack of comprehensive studies on iron status and cancer risk regarding most cancer types in the general population. 10 Thus, to investigate the link between iron status and cancer risk as well as cancer mortality in more detail, we evaluated associations between prediagnostic serum levels of ferritin, serum iron, transferrin, and TSAT and the risk of common cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC) -Heidelberg Study, using a large case-cohort sample. We hypothesized that higher iron load (as indicated by higher ferritin, higher iron, lower transferrin and higher TSAT) would be associated with increased cancer risk and mortality.
Materials and Methods

Study population
EPIC-Heidelberg was initiated as part of the European Prospective Investigation into Cancer and Nutrition (EPIC), a multicenter cohort study across 10 Western-European countries that started with 519 978 participants in the 1990s. 18 In Heidelberg, 13,611 female and 11,929 male participants aged 35-65 years were recruited from the local general population between 1994 and 1998. 19 At baseline, participants took part in a medical interview, anthropometric assessments and comprehensive questionnaire assessments on lifestyle factors, socio-economic status and habitual diet, the latter using a validated food frequency questionnaire (FFQ). 20, 21 In addition, blood samples were taken from 95% of the participants. Participants are followed up by active and passive procedures since the baseline. 22 The Ethics Committee of the Heidelberg University Hospital approved the study and all participants gave written informed consent. Self-reported and cancer registry-derived incident cases of cancer are validated by study physicians on the basis of medical records. For the present analyses on iron status and cancer risk, a case-cohort sample was used. 23 This sample includes a random subcohort of n 5 2,738, that is, about 10% of the entire EPIC-Heidelberg cohort, and incident cases of colorectal cancer (ICD-10 C18-C20 n 5 256), lung cancer (ICD-10 C34 n 5 195), breast cancer (ICD-10 C50 n 5 627), prostate cancer (ICD-10 C61 n 5 554) and cancer mortality (ICD-10 C00-D49 n 5 759) that occurred until December 31st 2009. The size of the subcohort guarantees a ratio of at least 2:1 between individuals in the subcohort and incident cases. Participants, who were randomly selected for the subcohort have characteristics that are highly similar to those of all study participants, for example, regarding age at baseline (50. 
Laboratory assessments
Blood samples were drawn, processed and stored at 21968 Celsius in liquid nitrogen. After sample retrieval for this study, a heated wire cutting system was used to open serum straws. Serum samples were put into measurement tubes and sent to the SHL Laboratories (Etten-Leur, Netherlands) for clinical chemistry measurement on dry ice. The Roche Cobas 6000 analytical system (Roche Diagnostics, Mannheim, Germany) was used to determine levels of ferritin, transferrin and iron as well as CRP in the same serum aliquot. TSAT was calculated as [(iron/transferrin) 3 70.9]. 24 Percentages of failed measurements were 3.2% for ferritin, 3.6% for transferrin, 9.5% for iron, 9.8% for TSAT and 3.6% for CRP overall. An overview of missing values by case status is given in Supporting Information, Table 1 . Multiple imputation of these missing values did not affect the results of the analyses presented below (data not shown), and we decided to carry out complete-case analyses.
Statistical analyses
Iron biomarkers and baseline characteristics of the study population are presented by mean values and standard deviations for continuous variables, and by frequencies for categorical variables. Cross-sectional associations between iron biomarkers and covariates were assessed by Generalized Linear Models adjusting for age and sex. FFQ-derived total red meat consumption was defined as the summed intake of unprocessed and processed red meat. For analyses on serum iron biomarkers in relation to cancer risk, we applied Cox proportional hazard regression models, following the weighting scheme proposed by Prentice. 25 We left-truncated at the age at entry and censored at the end of follow-up, loss to follow-up, date of death or date of What's new? While experimental evidence suggests carcinogenic effects of increased iron load, there is a lack of data on iron status and cancer risk from epidemiological studies. Here, the authors evaluated associations between prediagnostic serum levels of ferritin, serum iron, transferrin and transferrin saturation and the risk of common cancers using a large case-cohort sample. The established biomarkers of iron status were not associated with increased cancer risk. By contrast, higher serum ferritin was related to lower risks of breast cancer and cancer mortality. The findings suggest that higher iron load does not constitute a cancer risk factor in the general population.
diagnosis, whichever came first. A first "crude" Cox regression model was adjusted for age and sex. After the identification of potential confounders by literature search, all multivariable Cox regression analyses were carried out adjusting for waist circumference (cm), height (cm), alcohol consumption (g/day), CRP levels (mg/l), smoking status (former, never, current), education (primary school, secondary school, university degree), physical activity (Cambridge index), current aspirin use (yes/no), menopausal status (pre-and perimenopausal/postmenopausal), fiber intake (g/day), total red meat intake (g/day) and energy intake (kcal/day); analyses on breast cancer were further adjusted for current hormone replacement therapy (HRT) use (yes/no), current oral contraceptive use (yes/no) and parity (at least one full term pregnancy, yes/no). Statistical interactions between iron status markers and adjustment factors were tested for adding multiplicative terms into Cox regression models. All analyses were conducted with SAS 9.4 (Cary, NC, USA). Extended correlation tests based on Schoenfeld residuals did not indicate violations of the proportional hazards assumption. 26 
Results
Characteristics of the study population and correlates of iron biomarkers
Characteristics of the random subcohort and incident cancer cases are shown in Table 1 . Included in the subcohort were 1466 women and 1272 men, with mean ages of 49.5 and 52.6 at baseline. Women had lower mean ferritin levels (107.1 lg/l) than men (287.4 lg/l). Apart from breast cancer cases, incident cancer cases were more likely to be men, were older at baseline, had higher mean ferritin levels, consumed more alcohol and had higher BMI values, when compared to the overall subcohort. The average follow-up duration in the subcohort was 15.7 years, 8.0 years among colon cancer cases, 8.8 years among lung cancer cases, 8.4 years among breast cancer cases, 9.1 years among prostate cancer cases and 7.5 years among cases of cancer death.
Associations between biomarkers of iron status and covariates are shown in Supporting Information, Table 2 . Ferritin levels were positively associated with male sex, age, oral contraceptive use, BMI, CRP levels, red meat consumption and heme iron intake. Inverse associations were observed with education level and nonheme iron intake. These associations remained stable upon mutual adjustment for all covariates listed in Supporting Information, Table 2 , except for nonheme iron intake, which was no longer significantly associated with ferritin levels (data not shown). There were several nominally significant associations between the other iron status markers and covariates, although differences in marker levels across strata of covariates were less pronounced compared to ferritin (Supporting Information, Table 2 ).
Associations between iron status and cancer risk
Cox regression analyses on iron markers and cancer risk did not reveal significant associations, with the exception of breast cancer risk (Tables 2-6 Table 6 ). This association only became statistically significant after multivariable adjustment, while the age-and sex-adjusted Cox regression model had not shown a significant association (HR [95% CI]: 0.84 [0.66, 1.07], p for linear trend 5 0.28). There were no significant overall associations between the other iron biomarkers and cancer mortality ( Table 6 ). As a significant interaction between iron levels and sex (p < 0.01) was observed, additional analyses on cancer mortality were carried out stratifying by sex. These analyses showed tendencies for positive associations between iron levels and calculated TSAT with cancer mortality among men (Supporting Information, Table 3 ), but inverse associations among women (Supporting Information, Table 4 ).
Ancillary analyses
Analyses on cancer mortality by cancer type were restricted considering the number of cancer type-specific deaths. Cox Regression analyses on the four most frequent causes of cancer death (lung cancer, n 5 138; colon cancer, n 5 85; breast cancer, n 5 69; pancreatic cancer, n 5 29) yielded a significant inverse association between ferritin and colon cancerspecific death (HR [95% CI]: 0.77 [0.64, 0.91], p for linear trend 5 0.01), while no further significant associations were observed.
There were no further significant interactions between iron status markers and adjustment factors in relation to cancer risk or mortality. Our finding of a significant inverse association between ferritin levels and breast cancer risk (Table 2) , and the fact that ferritin levels were lower among premenopausal women (Supporting Information, Sensitivity analyses excluding cases that had occurred during the first 2 years of follow-up only marginally affected our results. None of the iron biomarkers was significantly associated
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Quintana Pacheco et al. According to the Cambridge Physical Activity Index. Results from Cox proportional hazards regression analyses; p values for linear trend obtained from multivariable Cox regression analyses with biomarker levels on the log2 scale modeled as continuous exposure variables. Model 1 was adjusted for age. Model 2 was additionally adjusted for waist circumference (cm), height (cm), alcohol consumption (g/day), CRP levels (mg/l), smoking status (former, never, current), education (primary school, secondary school, university degree), menopausal status (pre-and perimenopausal/postmenopausal), physical activity (Cambridge Index), current aspirin use (yes/no), fiber intake (g/day), total red meat intake (g/day) and energy intake (kcal/day), HRT use (yes/no), current oral contraceptive use (yes/no) and parity (at least one full-term pregnancy, yes/no). Results from Cox proportional hazards regression analyses; p values for linear trend obtained from multivariable Cox regression analyses with biomarker levels on the log2 scale modeled as continuous exposure variables. Model 1 was adjusted for age. Model 2 was additionally adjusted for waist circumference (cm), height (cm), alcohol consumption (g/day), CRP levels (mg/l), smoking status (former, never, current), education (primary school, secondary school, university degree), physical activity (Cambridge Index), current aspirin use (yes/no), fiber intake (g/day), total red meat intake (g/day) and energy intake (kcal/day).
Quintana Pacheco et al.
with colorectal cancer risk in Cox regression analyses restricted to different lag times (restricted to cases that had occurred within the first two, three, four, or five years of follow-up), which we carried out to assess potential reverse causality due to bleedings related to undiagnosed tumors or precursor lesions. Finally, Cox regression analyses on cancer risk among study participants with ferritin levels between 12 and 50 ng/ml, which have been proposed to decrease cancer risk in Western populations on the basis of a phlebotomy trial, 7 did not reveal significant differences compared to the rest of the study population (data not shown). Ferritin levels below 12 ng/ml indicating anemia were not associated with increased risks of cancer and cancer mortality (data not shown).
Discussion
In this study, we used data of the prospective EPIC-Heidelberg cohort to analyze whether ferritin, transferrin, TSAT and serum iron are associated with risks of common cancers and cancer mortality. Multivariable Cox regression models showed significant inverse associations between ferritin levels and breast cancer risk as well as cancer mortality, while there were no significant associations with risk of colorectal, prostate and lung cancer. With regard to serum iron, transferrin and TSAT, we did not observe any significant overall associations. However, analyses stratified by sex revealed a potential dimorphism regarding cancer mortality, with an inverse association between iron levels among women and a direct association among men.
Unlike three previous studies, our analyses did not show a significant inverse association between ferritin levels and colorectal cancer risk, [27] [28] [29] even though the present HR of 0.66 (0.44, 1.01) is still somewhat consistent with the notion of higher iron load being related to lower risk of gastrointestinal cancers. 10, 30 Moreover, we did observe a significant inverse association between ferritin and death due to colorectal cancer. Inverse associations between serum ferritin and risk of gastrointestinal cancers have been attributed to bleeding due to early lesions, with lower iron status reflecting a symptom of undiagnosed cancer rather than higher iron status constituting a protective factor. However, we did not find significant associations between ferritin and colorectal cancer risk in analyses restricted to cases that had occurred within two years after baseline. Alternatively, possible adverse effects of iron deficiency on immune parameters and DNA biosynthesis have been proposed to underlie such inverse associations between iron biomarkers and cancer risk. 30, 31 In this regard, it has to be noted that ferritin values <12 mg/l indicative of anemia were rare in our study (prevalence of 3.1% in the subcohort), and not associated with increased cancer risk.
Breast cancer risk was inversely associated with ferritin levels in the present study. The only previous populationbased study to our knowledge, in which ferritin was assessed in relation to breast cancer risk, was based on a smaller case number and did not reveal a significant association. 13 Considering that anemia and bleedings (see above) may not Results from Cox proportional hazards regression analyses; p values for linear trend obtained from multivariable Cox regression analyses with biomarker levels on the log2 scale modeled as continuous exposure variables. Model 1 was adjusted for age and sex. Model 2 was additionally adjusted for waist circumference (cm), height (cm), alcohol consumption (g/day), CRP levels (mg/l), smoking status (former, never, current), education (primary school, secondary school, university degree), menopausal status (pre-and perimenopausal/postmenopausal), physical activity (Cambridge Index), current aspirin use (yes/no), fiber intake (g/day), total red meat intake (g/day) and energy intake (kcal/day).
explain our finding of an inverse association between ferritin and breast cancer, a better understanding of the potential underlying mechanism is needed. This is also true with respect to the inverse association between ferritin and cancer mortality that we observed, given inconsistent findings from other studies: While ferritin was found to be inversely associated with cancer death among men in a smaller prospective survey from Australia, there was no significant association among women. 13 Another prospective survey from the USA showed no significant associations with cancer mortality, 32 and ferritin was positively associated with cancer mortality in a large-scale population-based study from Denmark. 33 Regarding serum iron (and calculated TSAT), we observed a positive association with cancer mortality among men, but an inverse association among women. Our finding among men is consistent with a positive association between TSAT and cancer mortality among male participants of the First National Health and Nutrition Examination Survey (NHANES) from the USA. 34 By contrast, higher TSAT and serum iron were related to increased risk of cancer death among women but not men in the Second NHANES, 35 while the Third NHANES showed an inverse association between TSAT and cancer mortality among men. 32 Two smaller prospective studies from Australia and the Netherlands did not reveal significant associations. 13, 36 Thus, the overall evidence on serum iron, TSAT and cancer mortality is rather heterogeneous and does not support the notion of a potential sexual dimorphism.
We did not observe significant associations between serum iron levels and TSAT with risks of breast, prostate, colorectal and lung cancer. Our findings on lung, prostate cancer, and colorectal cancer are in line with those from other prospective studies. 11, 13, 14, 27, 29 In contrast to our study that did not show associations between iron levels and breast cancer risk, three prospective studies did reveal increased breast cancer risk with higher iron levels or TSAT. 11, 13, 14 These latter results have been explained by potential iron-induced oxidative stress and DNA damage. 37 However, it remains somewhat spurious why these global mechanisms should not apply to other cancers, for which epidemiological studies do not indicate carcinogenic properties of iron. Possibly, excess iron may also potentiate effects of estradiol, but human evidence is missing. 37 Interestingly, ferritin, which is the established marker of excess iron, 38 was inversely associated with breast cancer risk in our study (see above), and it has been argued that TSAT and serum iron may be poorer proxies of iron status, also given their higher intraindividual variability. [39] [40] [41] Strengths of this study include its prospective design, the large sample size, the use of a comprehensive set of biomarkers and the meticulous adjustment for background risk factors. Nevertheless, it also has some limitations. Blood samples were only available from one time point; however, as stated above, at least ferritin concentrations show only moderate intraindividual variation over time. [39] [40] [41] We could not measure serum levels of hepcidin, a liver-derived peptide Results from Cox proportional hazards regression analyses; p values for linear trend obtained from multivariable Cox regression analyses with biomarker levels on the log2 scale modeled as continuous exposure variables. Model 1 was adjusted for age and sex. Model 2 was additionally adjusted for waist circumference (cm), height (cm), alcohol consumption (g/day), CRP levels (mg/l), smoking status (former, never, current), education (primary school, secondary school, university degree), menopausal status (pre-and perimenopausal/postmenopausal), physical activity (Cambridge Index), current aspirin use (yes/no), fiber intake (g/day), total red meat intake (g/day) and energy intake (kcal/day).
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hormone that leads to decreased iron absorption, and that has recently been shown to be inversely associated with gastric cancer risk. 42 In agreement with previous publications, cancer risk factors such as age, adiposity, inflammation or alcohol consumption were positively associated with ferritin levels in our study, and it can thus be questioned whether ferritin is an appropriate marker of iron load. Strikingly, however, adjustment for these factors did not affect the present inverse association between ferritin and breast cancer risk. Individuals with higher socio-economic status may be overrepresented in EPIC-Heidelberg, 19 which is why our novel finding on ferritin and breast cancer risk should be replicated in other cohorts. Finally, we only had sufficient statistical power for analyses on overall cancer mortality, while the numbers of cancer type-specific cases of death were low.
In summary, our results do not support the hypothesis that increased iron load may drive tumorigenesis. On the contrary, our data even suggest lower risk of breast cancer and cancer death with higher ferritin levels, which is in line with previous similar observations regarding colon cancer risk. Overall, the evidence on a potential link between iron status and cancer risk from human studies does not point to "ferrotoxicty" due to higher iron load constituting a cancer risk factor in the general population. Results from Cox proportional hazards regression analyses; p values for linear trend obtained from multivariable Cox regression analyses with biomarker levels on the log2 scale modeled as continuous exposure variables. Model 1 was adjusted for age and sex. Model 2 was additionally adjusted for waist circumference (cm), height (cm), alcohol consumption (g/day), CRP levels (mg/l), smoking status (former, never, current), education (primary school, secondary school, university degree), menopausal status (pre-and perimenopausal/postmenopausal), physical activity (Cambridge Index), current aspirin use (yes/no), fiber intake (g/day), total red meat intake (g/day) and energy intake (kcal/day).
